Virtual Reality Distraction During Pediatric Intravenous Line Placement
NCT ID: NCT03304769
Last Updated: 2017-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
116 participants
INTERVENTIONAL
2017-09-28
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to prospectively investigate the use of virtual reality headsets on the placement of IVs in a pediatric emergency department, by comparing the first stick success rate, total number of attempts, and the time to successful IV placement between patients who use virtual reality headset technology during the placement and those who receive the standard of care IV placement when child life ( individuals with special training in aiding and augmenting pediatric coping skills) is not available. The investigators will also compare the patient and parent perception of pain and anxiety associated with the IV placement in both study groups. Finally, by detailing which medications have been given prior to use of the VR for IV placement the investigators may evaluate for possible synergistic effects of VR with prior medication administration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IV placement no Virtual reality
Patient will have IV placed in traditional manner, with no virtual reality headset
No interventions assigned to this group
IV placement with Virtual Reality
Patient will have IV placed with Virtual Reality headset distraction
Virtual Reality
Virtual Reality Headset applied to the patient during placement of IV. Control is patient group without headset applied.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality
Virtual Reality Headset applied to the patient during placement of IV. Control is patient group without headset applied.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Requiring IV placement
* Child Life unavailable
Exclusion Criteria
* Physically/ developmentally unable to tolerate headset
* Skin/eye pathology
* Critically ill patient
* Language other than English or Spanish
* Student Nurse placing IV
4 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seton Healthcare Family
OTHER
University of Texas at Austin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dell Children's Medical Center of Central Texas
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Matthew Wilkinson, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASalinas
Identifier Type: -
Identifier Source: org_study_id